Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Absence of mutations in the LGL1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy

Identifieur interne : 002682 ( PascalFrancis/Curation ); précédent : 002681; suivant : 002683

Absence of mutations in the LGL1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy

Auteurs : Elodie Chabrol [France] ; Isabelle Gourfinkel An [France] ; Ingrid E. Scheffer [Australie] ; Fabienne Picard [Suisse] ; Philippe Couarch [France] ; Samuel F. Berkovic [Australie] ; Jacinta M. Mcmahon [Australie] ; Nandita Bajaj [Népal] ; Luisa Mota-Vieira [Portugal] ; Rui Mota [Portugal] ; Oriane Trouillard [France] ; Christel Depienne [France] ; Michel Baulac [France] ; Eric Leguern [France] ; Stephanie Baulac [France]

Source :

RBID : Pascal:07-0413971

Descripteurs français

English descriptors

Abstract

Mutations in the LGI1 (leucine-rich, glioma inactivated 1) gene are found in less than a half of the families with autosomal dominant lateral temporal epilepsy (ADLTE), suggesting that ADLTE is a genetically heterogeneous disorder. Recently, it was shown that LGI1 is released by neurons and becomes part of a protein complex at the neuronal postsynaptic density where it is implicated in the regulation of glutamate-AMPA neurotransmission. Within this complex, LGI1 binds selectively to a neuronal specific membrane protein, ADAM22 (a disintegrin and metalloprotease). Since ADAM22 serves as a neuronal receptor for LGI1, the ADAM22 gene was considered a good candidate gene for ADLTE. We have therefore sequenced all coding exons and exon-intron flanking sites in the ADAM22 gene in the probands of 18 ADLTE families negative for LGI1 mutations. Although, we identified several synonymous and non-synonymous polymorphisms, we failed to identify disease-causing mutations, indicating that ADAM22 gene is probably not a major gene for this epilepsy syndrome.
pA  
A01 01  1    @0 0920-1211
A02 01      @0 EPIRE8
A03   1    @0 Epilepsy res.
A05       @2 76
A06       @2 1
A08 01  1  ENG  @1 Absence of mutations in the LGL1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy
A11 01  1    @1 CHABROL (Elodie)
A11 02  1    @1 GOURFINKEL -AN (Isabelle)
A11 03  1    @1 SCHEFFER (Ingrid E.)
A11 04  1    @1 PICARD (Fabienne)
A11 05  1    @1 COUARCH (Philippe)
A11 06  1    @1 BERKOVIC (Samuel F.)
A11 07  1    @1 MCMAHON (Jacinta M.)
A11 08  1    @1 BAJAJ (Nandita)
A11 09  1    @1 MOTA-VIEIRA (Luisa)
A11 10  1    @1 MOTA (Rui)
A11 11  1    @1 TROUILLARD (Oriane)
A11 12  1    @1 DEPIENNE (Christel)
A11 13  1    @1 BAULAC (Michel)
A11 14  1    @1 LEGUERN (Eric)
A11 15  1    @1 BAULAC (Stephanie)
A14 01      @1 INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere @2 Paris @3 FRA @Z 1 aut. @Z 2 aut. @Z 5 aut. @Z 12 aut. @Z 14 aut. @Z 15 aut.
A14 02      @1 Université Pierre et Marie Curie, Faculté de Medecine @2 Paris @3 FRA @Z 1 aut. @Z 2 aut. @Z 5 aut. @Z 12 aut. @Z 14 aut. @Z 15 aut.
A14 03      @1 Epileptology unit, AP-HP, Hopital de la Pitié -Salpêtrière @2 Paris @3 FRA @Z 2 aut. @Z 13 aut.
A14 04      @1 Epilepsy Research Centre, University of Melbourne, Austin Health @3 AUS @Z 3 aut. @Z 6 aut. @Z 7 aut.
A14 05      @1 Department of Paediatrics, University of Melbourne, Royal Children's Hospital @3 AUS @Z 3 aut.
A14 06      @1 Department of Neurology, University Hospital and Medical School of Geneva @2 Geneva @3 CHE @Z 4 aut.
A14 07      @1 Epilepsy clinic, Siddharth Hospital Ltd @2 Kathmandu @3 NPL @Z 8 aut.
A14 08      @1 Hospital do Divino Espirito Santo @2 Acores @3 PRT @Z 9 aut. @Z 10 aut.
A14 09      @1 AP-Hf Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique @2 75013 Paris @3 FRA @Z 11 aut. @Z 12 aut. @Z 14 aut.
A20       @1 41-48
A21       @1 2007
A23 01      @0 ENG
A43 01      @1 INIST @2 21149 @5 354000161591710060
A44       @0 0000 @1 © 2007 INIST-CNRS. All rights reserved.
A45       @0 3/4 p.
A47 01  1    @0 07-0413971
A60       @1 P @3 PR
A61       @0 A
A64 01  1    @0 Epilepsy research
A66 01      @0 NLD
C01 01    ENG  @0 Mutations in the LGI1 (leucine-rich, glioma inactivated 1) gene are found in less than a half of the families with autosomal dominant lateral temporal epilepsy (ADLTE), suggesting that ADLTE is a genetically heterogeneous disorder. Recently, it was shown that LGI1 is released by neurons and becomes part of a protein complex at the neuronal postsynaptic density where it is implicated in the regulation of glutamate-AMPA neurotransmission. Within this complex, LGI1 binds selectively to a neuronal specific membrane protein, ADAM22 (a disintegrin and metalloprotease). Since ADAM22 serves as a neuronal receptor for LGI1, the ADAM22 gene was considered a good candidate gene for ADLTE. We have therefore sequenced all coding exons and exon-intron flanking sites in the ADAM22 gene in the probands of 18 ADLTE families negative for LGI1 mutations. Although, we identified several synonymous and non-synonymous polymorphisms, we failed to identify disease-causing mutations, indicating that ADAM22 gene is probably not a major gene for this epilepsy syndrome.
C02 01  X    @0 002B17A03
C02 02  X    @0 002B02B06
C03 01  X  FRE  @0 Epilepsie @5 01
C03 01  X  ENG  @0 Epilepsy @5 01
C03 01  X  SPA  @0 Epilepsia @5 01
C03 02  X  FRE  @0 Mutation @5 09
C03 02  X  ENG  @0 Mutation @5 09
C03 02  X  SPA  @0 Mutación @5 09
C03 03  X  FRE  @0 Récepteur biologique @5 10
C03 03  X  ENG  @0 Biological receptor @5 10
C03 03  X  SPA  @0 Receptor biológico @5 10
C07 01  X  FRE  @0 Encéphale pathologie @5 37
C07 01  X  ENG  @0 Cerebral disorder @5 37
C07 01  X  SPA  @0 Encéfalo patología @5 37
C07 02  X  FRE  @0 Système nerveux central pathologie @5 38
C07 02  X  ENG  @0 Central nervous system disease @5 38
C07 02  X  SPA  @0 Sistema nervosio central patología @5 38
C07 03  X  FRE  @0 Système nerveux pathologie @5 39
C07 03  X  ENG  @0 Nervous system diseases @5 39
C07 03  X  SPA  @0 Sistema nervioso patología @5 39
N21       @1 267
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:07-0413971

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Absence of mutations in the LGL1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy</title>
<author>
<name sortKey="Chabrol, Elodie" sort="Chabrol, Elodie" uniqKey="Chabrol E" first="Elodie" last="Chabrol">Elodie Chabrol</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Gourfinkel An, Isabelle" sort="Gourfinkel An, Isabelle" uniqKey="Gourfinkel An I" first="Isabelle" last="Gourfinkel An">Isabelle Gourfinkel An</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Epileptology unit, AP-HP, Hopital de la Pitié -Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Scheffer, Ingrid E" sort="Scheffer, Ingrid E" uniqKey="Scheffer I" first="Ingrid E." last="Scheffer">Ingrid E. Scheffer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Epilepsy Research Centre, University of Melbourne, Austin Health</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Department of Paediatrics, University of Melbourne, Royal Children's Hospital</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Picard, Fabienne" sort="Picard, Fabienne" uniqKey="Picard F" first="Fabienne" last="Picard">Fabienne Picard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Department of Neurology, University Hospital and Medical School of Geneva</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author>
<name sortKey="Couarch, Philippe" sort="Couarch, Philippe" uniqKey="Couarch P" first="Philippe" last="Couarch">Philippe Couarch</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Berkovic, Samuel F" sort="Berkovic, Samuel F" uniqKey="Berkovic S" first="Samuel F." last="Berkovic">Samuel F. Berkovic</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Epilepsy Research Centre, University of Melbourne, Austin Health</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Mcmahon, Jacinta M" sort="Mcmahon, Jacinta M" uniqKey="Mcmahon J" first="Jacinta M." last="Mcmahon">Jacinta M. Mcmahon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Epilepsy Research Centre, University of Melbourne, Austin Health</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Bajaj, Nandita" sort="Bajaj, Nandita" uniqKey="Bajaj N" first="Nandita" last="Bajaj">Nandita Bajaj</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Epilepsy clinic, Siddharth Hospital Ltd</s1>
<s2>Kathmandu</s2>
<s3>NPL</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Népal</country>
</affiliation>
</author>
<author>
<name sortKey="Mota Vieira, Luisa" sort="Mota Vieira, Luisa" uniqKey="Mota Vieira L" first="Luisa" last="Mota-Vieira">Luisa Mota-Vieira</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Hospital do Divino Espirito Santo</s1>
<s2>Acores</s2>
<s3>PRT</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author>
<name sortKey="Mota, Rui" sort="Mota, Rui" uniqKey="Mota R" first="Rui" last="Mota">Rui Mota</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Hospital do Divino Espirito Santo</s1>
<s2>Acores</s2>
<s3>PRT</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author>
<name sortKey="Trouillard, Oriane" sort="Trouillard, Oriane" uniqKey="Trouillard O" first="Oriane" last="Trouillard">Oriane Trouillard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>AP-Hf Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Depienne, Christel" sort="Depienne, Christel" uniqKey="Depienne C" first="Christel" last="Depienne">Christel Depienne</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>AP-Hf Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Baulac, Michel" sort="Baulac, Michel" uniqKey="Baulac M" first="Michel" last="Baulac">Michel Baulac</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Epileptology unit, AP-HP, Hopital de la Pitié -Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Leguern, Eric" sort="Leguern, Eric" uniqKey="Leguern E" first="Eric" last="Leguern">Eric Leguern</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>AP-Hf Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Baulac, Stephanie" sort="Baulac, Stephanie" uniqKey="Baulac S" first="Stephanie" last="Baulac">Stephanie Baulac</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">07-0413971</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0413971 INIST</idno>
<idno type="RBID">Pascal:07-0413971</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003A06</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002682</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Absence of mutations in the LGL1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy</title>
<author>
<name sortKey="Chabrol, Elodie" sort="Chabrol, Elodie" uniqKey="Chabrol E" first="Elodie" last="Chabrol">Elodie Chabrol</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Gourfinkel An, Isabelle" sort="Gourfinkel An, Isabelle" uniqKey="Gourfinkel An I" first="Isabelle" last="Gourfinkel An">Isabelle Gourfinkel An</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Epileptology unit, AP-HP, Hopital de la Pitié -Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Scheffer, Ingrid E" sort="Scheffer, Ingrid E" uniqKey="Scheffer I" first="Ingrid E." last="Scheffer">Ingrid E. Scheffer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Epilepsy Research Centre, University of Melbourne, Austin Health</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Department of Paediatrics, University of Melbourne, Royal Children's Hospital</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Picard, Fabienne" sort="Picard, Fabienne" uniqKey="Picard F" first="Fabienne" last="Picard">Fabienne Picard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Department of Neurology, University Hospital and Medical School of Geneva</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author>
<name sortKey="Couarch, Philippe" sort="Couarch, Philippe" uniqKey="Couarch P" first="Philippe" last="Couarch">Philippe Couarch</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Berkovic, Samuel F" sort="Berkovic, Samuel F" uniqKey="Berkovic S" first="Samuel F." last="Berkovic">Samuel F. Berkovic</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Epilepsy Research Centre, University of Melbourne, Austin Health</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Mcmahon, Jacinta M" sort="Mcmahon, Jacinta M" uniqKey="Mcmahon J" first="Jacinta M." last="Mcmahon">Jacinta M. Mcmahon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Epilepsy Research Centre, University of Melbourne, Austin Health</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Bajaj, Nandita" sort="Bajaj, Nandita" uniqKey="Bajaj N" first="Nandita" last="Bajaj">Nandita Bajaj</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Epilepsy clinic, Siddharth Hospital Ltd</s1>
<s2>Kathmandu</s2>
<s3>NPL</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Népal</country>
</affiliation>
</author>
<author>
<name sortKey="Mota Vieira, Luisa" sort="Mota Vieira, Luisa" uniqKey="Mota Vieira L" first="Luisa" last="Mota-Vieira">Luisa Mota-Vieira</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Hospital do Divino Espirito Santo</s1>
<s2>Acores</s2>
<s3>PRT</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author>
<name sortKey="Mota, Rui" sort="Mota, Rui" uniqKey="Mota R" first="Rui" last="Mota">Rui Mota</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Hospital do Divino Espirito Santo</s1>
<s2>Acores</s2>
<s3>PRT</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author>
<name sortKey="Trouillard, Oriane" sort="Trouillard, Oriane" uniqKey="Trouillard O" first="Oriane" last="Trouillard">Oriane Trouillard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>AP-Hf Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Depienne, Christel" sort="Depienne, Christel" uniqKey="Depienne C" first="Christel" last="Depienne">Christel Depienne</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>AP-Hf Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Baulac, Michel" sort="Baulac, Michel" uniqKey="Baulac M" first="Michel" last="Baulac">Michel Baulac</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Epileptology unit, AP-HP, Hopital de la Pitié -Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Leguern, Eric" sort="Leguern, Eric" uniqKey="Leguern E" first="Eric" last="Leguern">Eric Leguern</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>AP-Hf Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Baulac, Stephanie" sort="Baulac, Stephanie" uniqKey="Baulac S" first="Stephanie" last="Baulac">Stephanie Baulac</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Epilepsy research</title>
<title level="j" type="abbreviated">Epilepsy res.</title>
<idno type="ISSN">0920-1211</idno>
<imprint>
<date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Epilepsy research</title>
<title level="j" type="abbreviated">Epilepsy res.</title>
<idno type="ISSN">0920-1211</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Biological receptor</term>
<term>Epilepsy</term>
<term>Mutation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Epilepsie</term>
<term>Mutation</term>
<term>Récepteur biologique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mutations in the LGI1 (leucine-rich, glioma inactivated 1) gene are found in less than a half of the families with autosomal dominant lateral temporal epilepsy (ADLTE), suggesting that ADLTE is a genetically heterogeneous disorder. Recently, it was shown that LGI1 is released by neurons and becomes part of a protein complex at the neuronal postsynaptic density where it is implicated in the regulation of glutamate-AMPA neurotransmission. Within this complex, LGI1 binds selectively to a neuronal specific membrane protein, ADAM22 (a disintegrin and metalloprotease). Since ADAM22 serves as a neuronal receptor for LGI1, the ADAM22 gene was considered a good candidate gene for ADLTE. We have therefore sequenced all coding exons and exon-intron flanking sites in the ADAM22 gene in the probands of 18 ADLTE families negative for LGI1 mutations. Although, we identified several synonymous and non-synonymous polymorphisms, we failed to identify disease-causing mutations, indicating that ADAM22 gene is probably not a major gene for this epilepsy syndrome.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0920-1211</s0>
</fA01>
<fA02 i1="01">
<s0>EPIRE8</s0>
</fA02>
<fA03 i2="1">
<s0>Epilepsy res.</s0>
</fA03>
<fA05>
<s2>76</s2>
</fA05>
<fA06>
<s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Absence of mutations in the LGL1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>CHABROL (Elodie)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>GOURFINKEL -AN (Isabelle)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>SCHEFFER (Ingrid E.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>PICARD (Fabienne)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>COUARCH (Philippe)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>BERKOVIC (Samuel F.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>MCMAHON (Jacinta M.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>BAJAJ (Nandita)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>MOTA-VIEIRA (Luisa)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>MOTA (Rui)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>TROUILLARD (Oriane)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>DEPIENNE (Christel)</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>BAULAC (Michel)</s1>
</fA11>
<fA11 i1="14" i2="1">
<s1>LEGUERN (Eric)</s1>
</fA11>
<fA11 i1="15" i2="1">
<s1>BAULAC (Stephanie)</s1>
</fA11>
<fA14 i1="01">
<s1>INSERM U679, Neurology and Experimental Therapeutics, Hopital de la Salpetriere</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Université Pierre et Marie Curie, Faculté de Medecine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Epileptology unit, AP-HP, Hopital de la Pitié -Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Epilepsy Research Centre, University of Melbourne, Austin Health</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Department of Paediatrics, University of Melbourne, Royal Children's Hospital</s1>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Department of Neurology, University Hospital and Medical School of Geneva</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Epilepsy clinic, Siddharth Hospital Ltd</s1>
<s2>Kathmandu</s2>
<s3>NPL</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>Hospital do Divino Espirito Santo</s1>
<s2>Acores</s2>
<s3>PRT</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="09">
<s1>AP-Hf Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique et Cytogénétique</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>14 aut.</sZ>
</fA14>
<fA20>
<s1>41-48</s1>
</fA20>
<fA21>
<s1>2007</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>21149</s2>
<s5>354000161591710060</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>3/4 p.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>07-0413971</s0>
</fA47>
<fA60>
<s1>P</s1>
<s3>PR</s3>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Epilepsy research</s0>
</fA64>
<fA66 i1="01">
<s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Mutations in the LGI1 (leucine-rich, glioma inactivated 1) gene are found in less than a half of the families with autosomal dominant lateral temporal epilepsy (ADLTE), suggesting that ADLTE is a genetically heterogeneous disorder. Recently, it was shown that LGI1 is released by neurons and becomes part of a protein complex at the neuronal postsynaptic density where it is implicated in the regulation of glutamate-AMPA neurotransmission. Within this complex, LGI1 binds selectively to a neuronal specific membrane protein, ADAM22 (a disintegrin and metalloprotease). Since ADAM22 serves as a neuronal receptor for LGI1, the ADAM22 gene was considered a good candidate gene for ADLTE. We have therefore sequenced all coding exons and exon-intron flanking sites in the ADAM22 gene in the probands of 18 ADLTE families negative for LGI1 mutations. Although, we identified several synonymous and non-synonymous polymorphisms, we failed to identify disease-causing mutations, indicating that ADAM22 gene is probably not a major gene for this epilepsy syndrome.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17A03</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Epilepsie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Epilepsy</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Epilepsia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Mutation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Mutation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Mutación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Récepteur biologique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Biological receptor</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Receptor biológico</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>39</s5>
</fC07>
<fN21>
<s1>267</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002682 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002682 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:07-0413971
   |texte=   Absence of mutations in the LGL1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024